BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18000817)

  • 1. Hippocampus of Ames dwarf mice is resistant to beta-amyloid-induced tau hyperphosphorylation and changes in apoptosis-regulatory protein levels.
    Schrag M; Sharma S; Brown-Borg H; Ghribi O
    Hippocampus; 2008; 18(3):239-44. PubMed ID: 18000817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice.
    Naert G; Ferré V; Meunier J; Keller E; Malmström S; Givalois L; Carreaux F; Bazureau JP; Maurice T
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2170-82. PubMed ID: 26381812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo.
    Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS
    J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons.
    Alvarez AR; Godoy JA; Mullendorff K; Olivares GH; Bronfman M; Inestrosa NC
    Exp Cell Res; 2004 Jul; 297(1):186-96. PubMed ID: 15194435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium inhibits Abeta-induced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation.
    Ghribi O; Herman MM; Savory J
    J Neurosci Res; 2003 Mar; 71(6):853-62. PubMed ID: 12605412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1.
    Scali C; Caraci F; Gianfriddo M; Diodato E; Roncarati R; Pollio G; Gaviraghi G; Copani A; Nicoletti F; Terstappen GC; Caricasole A
    Neurobiol Dis; 2006 Nov; 24(2):254-65. PubMed ID: 16919965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.
    Lahmy V; Meunier J; Malmström S; Naert G; Givalois L; Kim SH; Villard V; Vamvakides A; Maurice T
    Neuropsychopharmacology; 2013 Aug; 38(9):1706-23. PubMed ID: 23493042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein arginine methyltransferase PRMT5 regulates Aβ-induced toxicity in human cells and Caenorhabditis elegans models of Alzheimer's disease.
    Quan X; Yue W; Luo Y; Cao J; Wang H; Wang Y; Lu Z
    J Neurochem; 2015 Sep; 134(5):969-77. PubMed ID: 26086249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
    Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
    Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
    J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation.
    Hu WY; He ZY; Yang LJ; Zhang M; Xing D; Xiao ZC
    Br J Pharmacol; 2015 May; 172(9):2273-85. PubMed ID: 25521332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
    Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
    Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease.
    Alvarez G; Muñoz-Montaño JR; Satrústegui J; Avila J; Bogónez E; Díaz-Nido J
    Bipolar Disord; 2002 Jun; 4(3):153-65. PubMed ID: 12180271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
    Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
    Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
    Hu M; Waring JF; Gopalakrishnan M; Li J
    J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain.
    Caricasole A; Copani A; Caraci F; Aronica E; Rozemuller AJ; Caruso A; Storto M; Gaviraghi G; Terstappen GC; Nicoletti F
    J Neurosci; 2004 Jun; 24(26):6021-7. PubMed ID: 15229249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
    Zhu C; Xu B; Sun X; Zhu Q; Sui Y
    Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.